A drug originally developed to treat type 2 diabetes may protect the heart. Early research shows IC7Fc can lower cholesterol, ...
An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc ...
Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...
HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...
A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill ...
SHANGHAI, Jan 30 () - Sciwind Biosciences' type 2 diabetes treatment Xianyida was approved for use in China, the company ...
Everyday Health on MSN
SGLT2 inhibitors and IgAN: Can this diabetes drug delay kidney decline?
Explore the potential of SGLT2 inhibitors for IgAN. Learn how these diabetes drugs slow kidney damage progression when added to standard treatment.
Mounjaro is a new medication used to manage blood sugar levels in people who have type 2 diabetes. This medication offers weight loss and cardiovascular benefits, which can also help with insulin ...
11don MSN
Common diabetes drug fails to improve walking performance in peripheral artery disease patients
A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...
A lab study in donated human pancreatic islets found that chronic exposure to glibenclamide (a sulphonylurea) reduced glucose responsive insulin release and increased beta cell stress and cell death ...
11don MSN
Type 2 diabetes prevention could more than halve carbon footprint linked to disease complications
Preventing high blood glucose (pre-diabetes) from turning into type 2 diabetes with lifestyle changes could more than halve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results